At the end of September, Barcelona will renew its vocation as one of the main European capitals for medical congresses. It will host the World Congress on Lung Cancer, the the Annual Congress of the European Association for the Study of Diabetes and the Annual Congress of the European Society for Medical Oncology.
They will all be held at the Gran Via site, which will become a major platform for discussion and debate between experts on the main challenges that medicine is facing. Cancer and diabetes, along with cardiovascular and respiratory diseases, are responsible for most of the deaths caused by non-infectious diseases today, according to the World Health Organization.
These top-ranking professional events, which Fira has made a concerted effort to attract for several years, reinforce Barcelona’s status as a city with a high profile in healthcare, due to the quality of its hospitals and research centres and its role a global meeting place for the exchange of information and techniques. It is home to several pioneering centres of medical excellence in research, including the University Hospital Vall d’Hebron, Hospital Clínic and Bellvitge Hospital. They are joined by the Institute for Biomedical Research and the AIDS Research Institute (IRSI), which are examples of research centres in Barcelona that are at the forefront of medicine thanks to their technical advances, innovation and technology.
Professionals from all around the world
These three medical congresses are expected to attract 50,000 health professionals to the capital of Catalonia. They form part of the thirty or so major congresses that are included in Fira’s calendar for 2019.
- Congress of the European Society for Medical Oncology (ESMO). This is one of the most outstanding of the 14 medical congresses that Fira de Barcelona is hosting in 2019. The congress, under the motto “Translating science into better cancer patient care”, will benefit from the participation of more than 28,000 experts, twice as many as its 2018 edition. The organizers said that they have chosen Spain to hold three of the last six editions of this European congress because of the quality of the country’s medical research system and international cooperation in the field of oncology. The programme for the Barcelona event, between 27 September and 1 October, was prepared by more than 300 experts.
- Annual Congress of the European Association for the Study of Diabetes (EASD). This will be held on September 16 to 20 and will discuss the progress in research and prevention of diabetes with an expected audience of 15,000 professional attendees. According to WHO data, diabetes currently affects one person in eleven and the number of cases has increased fourfold since 1990, making it a whole new challenge for the medical community. With this in mind, this year’s edition of the congress aims to encourage and support research into diabetes, contribute to faster awareness of new studies into the disease and simplify the application of new techniques and discoveries.
- World Congress on Lung Cancer (IASCL). This is the largest international meeting for practitioners in this field of medicine and research, attracting specialists in lung cancer and thoracic oncology. More than 7,000 international experts are expected to attend its twentieth edition, from 7 to 10 September. Besides the conferences and presentations about the latest advances in prevention and treatment of lung cancer, this year’s programme also includes interactive breakfasts, workshops and networking sessions aimed at other profiles in the medical field, such as nurses or the oncology patients themselves.